Get started
111

GRAPE KING BIO LTD

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

1707 chart


Full chart

1707 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪22.59 B‬ TWD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
15.5
Basic EPS (TTM)
10.0 TWD
Net income (FY)
‪1.45 B‬ TWD
Revenue (FY)
‪10.63 B‬ TWD
Shares float
‪120.77 M‬
Beta (1Y)
0.10

About GRAPE KING BIO LTD


Sector
Health Technology
CEO
Sheng Lin Tseng
Headquarters
Taoyuan
Website
grapeking.com.tw
Founded
1971
ISIN
TW0001707008
FIGI
BBG000BDB8Y1
Grape King Bio Ltd. engages in the production and sale of pharmaceutical preparations, patent medicine, liquid tonics, drinks, and healthy food. It operates through the following segments: Multi-Level Marketing (MLM), Distributors, and Original Design Manufacturer/Original Equipment Manufacturer (ODM/OEM). The MLM segment is involved in the direct seller of Pro-partner Inc., including the company’s development and manufacturing products for Pro-partner Inc., The Distributors segment include GRAPE KING BIO’s self-owned brand products. The ODM/OEM segment refers to the ODM/OEM in Taiwan and Shanghai. The company was founded by Shui Chao Tseng on April 1, 1971 and is headquartered in Taoyuan, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

1707 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 1707 is 152.0 TWD — it has increased by 0.99% in the past 24 hours. Watch GRAPE KING BIO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange GRAPE KING BIO LTD stocks are traded under the ticker 1707.
1707 stock has risen by 0.99% compared to the previous week, the month change is a 0.33% rise, over the last year GRAPE KING BIO LTD has showed a −0.33% decrease.
We've gathered analysts' opinions on GRAPE KING BIO LTD future price: according to them, 1707 price has a max estimate of 168.00 TWD and a min estimate of 166.00 TWD. Watch 1707 chart and read a more detailed GRAPE KING BIO LTD stock forecast: see what analysts think of GRAPE KING BIO LTD and suggest that you do with its stocks.
1707 reached its all-time high on Oct 20, 2016 with the price of 282.0 TWD, and its all-time low was 7.5 TWD and was reached on Sep 22, 2005. View more price dynamics on 1707 chart.
See other stocks reaching their highest and lowest prices.
1707 stock is 1.32% volatile and has beta coefficient of 0.10. Track GRAPE KING BIO LTD stock price on the chart and check out the list of the most volatile stocks — is GRAPE KING BIO LTD there?
Today GRAPE KING BIO LTD has the market capitalization of ‪22.59 B‬, it has increased by 0.66% over the last week.
Yes, you can track GRAPE KING BIO LTD financials in yearly and quarterly reports right on TradingView.
GRAPE KING BIO LTD is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
1707 earnings for the last quarter are 2.25 TWD per share, whereas the estimation was 2.25 TWD resulting in a 0.00% surprise. The estimated earnings for the next quarter are 3.52 TWD per share. See more details about GRAPE KING BIO LTD earnings.
GRAPE KING BIO LTD revenue for the last quarter amounts to ‪2.70 B‬ TWD, despite the estimated figure of ‪2.70 B‬ TWD. In the next quarter, revenue is expected to reach ‪3.49 B‬ TWD.
1707 net income for the last quarter is ‪415.89 M‬ TWD, while the quarter before that showed ‪327.76 M‬ TWD of net income which accounts for 26.89% change. Track more GRAPE KING BIO LTD financial stats to get the full picture.
GRAPE KING BIO LTD dividend yield was 4.42% in 2023, and payout ratio reached 70.36%. The year before the numbers were 4.11% and 70.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GRAPE KING BIO LTD EBITDA is ‪3.05 B‬ TWD, and current EBITDA margin is 27.73%. See more stats in GRAPE KING BIO LTD financial statements.
Like other stocks, 1707 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRAPE KING BIO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GRAPE KING BIO LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GRAPE KING BIO LTD stock shows the sell signal. See more of GRAPE KING BIO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.